Thomas Gallagher Selected Research

Thomas Gallagher Research Topics

4	Infections 04/2010 - 09/2005
1	Muscular Dystrophies (Muscular Dystrophy) 09/2023
1	Opioid-Related Disorders (Opiate Addiction) 01/2022
1	Mood Disorders (Mood Disorder) 01/2022
1	COVID-19 01/2022
1	Lymphopenia (Lymphocytopenia) 01/2021
1	Alzheimer Disease (Alzheimer's Disease) 01/2020
1	Hyperglycemia 01/2020
1	Hyperinsulinism (Hyperinsulinemia) 01/2020
1	Insulin Resistance 01/2020
1	Lipodystrophy 01/2020
1	Hypopigmentation (Hypomelanosis) 01/2020
1	Hidradenitis Suppurativa 01/2020
1	Disease Progression 05/2017
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 05/2017
1	Pain (Aches) 01/2017
1	Dehydration (Water Stress) 01/2017
1	Shock 01/2017
1	Coronavirus Infections 09/2005
1	Severe Acute Respiratory Syndrome 09/2005
1	Encephalitis (Encephalitis, Rasmussen) 09/2005

4	Proteins (Proteins, Gene)FDA Link 04/2010 - 09/2005
2	Transcription Factors (Transcription Factor)IBA 01/2017 - 04/2010
1	DystrophinIBA 09/2023
1	Trans-Activators (Trans-Acting Factor)IBA 09/2023
1	Nicotine FDA Link 01/2022
1	Antigen Receptors (Antigen Receptor)IBA 01/2021
1	Amyloid Precursor Protein Secretases (beta-Secretase)IBA 01/2020
1	Ethylnitrosourea (N-Ethyl-N-nitrosourea)IBA 01/2020
1	Insulin (Novolin)FDA Link 01/2020
1	LipidsIBA 01/2020
1	Biomarkers (Surrogate Marker)IBA 05/2017
1	Abscisic AcidIBA 01/2017
1	Coffee FDA Link 01/2017
1	Membrane Proteins (Integral Membrane Proteins)IBA 04/2010
1	Viral ProteinsIBA 02/2007

1	Therapeutics 09/2023
1	Personal Protective Equipment 01/2022
1	Mechanical Ventilators (Ventilator) 01/2022
1	Length of Stay 01/2017